The EP2 agonist, omidenepag, alters the physical stiffness of 3D spheroids prepared from human corneal stroma fibroblasts differently depending on the osmotic pressure

FASEB J. 2022 Jan;36(1):e22067. doi: 10.1096/fj.202101263R.

Abstract

The objective of the current study was to examine the drug-induced effects of the EP2 agonist, omidenapag (OMD), on human corneal stroma, two- and three-dimensional (2D and 3D) cultures of human corneal stroma fibroblasts (HCSFs). The drug-induced effects on 2D monolayers and 3D spheroids were characterized by examining the ultrastructures by scanning electron microscope (SEM), transendothelial electrical resistance (TEER) measurements, and fluorescein isothiocyanate (FITC)-dextran permeability. The physical properties of 3D spheroids with respect to size and stiffness were also examined. In addition, the gene expressions of extracellular matrix (ECM) molecules, including collagen (COL) 1, 4, and 6, and fibronectin (FN), a tissue inhibitor of metalloproteinase (TIMP) 1-4, matrix metalloproteinase (MMP) 2, 9, and 14, aquaporin1 (AQP1), and several endoplasmic reticulum (ER) stress-related factors were evaluated. In the 2D HCSFs, OMD induced (1) a significant increase in ECM deposits, as evidenced by SEM, the mRNA expression of COL4 and FN, and (2) a decrease in TEER values and a concentration-dependent increase in FITC-dextran permeability. In the case of 3D spheroids, OMD had no effect on size but a substantial increase in stiffness was observed. Furthermore, such OMD-induced effects on stiffness were dramatically modulated by the osmotic pressure of the system. In contrast to the above 2D cultures, among the ECM molecules and the modulators of 3D spheroids, namely, TIMPS and MMPs, the down-regulation of COL1, TIMP1 and 2 and the up-regulation of MMP9 were observed. Interestingly, such diversity in terms of OMD-induced gene expressions between 2D and 3D cultures was also recognized in AQP1 (2D; no significant change, 3D; significant up-regulation) and ER stress-related genes. The findings presented herein suggest that the EP2 agonist, OMD, alters the physical stiffness of 3D spheroids obtained from human corneal stroma fibroblasts and this alteration is dependent on the osmotic pressures. 2D and 3D cell cultures may be useful for evaluating the drug induced effects of OMD toward human corneal stroma.

Keywords: 3D spheroid culture; EP2 agonist; human corneal stroma fibroblasts (HCSFs); omidenepag (OMD); osmotic pressures.

Publication types

  • Clinical Trial

MeSH terms

  • Cornea / metabolism*
  • Cornea / ultrastructure
  • Endoplasmic Reticulum Stress
  • Extracellular Matrix / metabolism
  • Extracellular Matrix / ultrastructure
  • Eye Proteins / metabolism
  • Female
  • Fibroblasts / metabolism*
  • Fibroblasts / ultrastructure
  • Humans
  • Male
  • Osmotic Pressure / drug effects*
  • Receptors, Prostaglandin E, EP2 Subtype* / agonists
  • Receptors, Prostaglandin E, EP2 Subtype* / metabolism
  • Spheroids, Cellular / metabolism*
  • Spheroids, Cellular / ultrastructure

Substances

  • Eye Proteins
  • PTGER2 protein, human
  • Receptors, Prostaglandin E, EP2 Subtype